Massachusetts General Hospital_Site number 002 — Boston, Massachusetts

Massachusetts General Hospital_Site number 002 is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Clinical Trials Trust Score: 93/100 (GOOD). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital_Site number 002 has participated in 1 clinical trials.

Therapeutic areas: System; Sclerosis, Diffuse Cutaneous Systemic Sclerosis.

Sponsors: Kadmon, a Sanofi Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boston

Browse all research sites in Massachusetts · View every site in Boston

Sponsor Feasibility Report

Trust Score: 93/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital_Site number 002?

Massachusetts General Hospital_Site number 002 has a Crixeo Trust Score of 93/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital_Site number 002 conducted?

Massachusetts General Hospital_Site number 002 has 1 clinical trials on record. Their work covers System; Sclerosis, Diffuse Cutaneous Systemic Sclerosis.

Is Massachusetts General Hospital_Site number 002 accredited by Crixeo Clinical Trials?

Massachusetts General Hospital_Site number 002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital_Site number 002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.